Streamline Health Solutions, Inc. Forecast, price target & analysts
Streamline Health Solutions, Inc. Target price 2025 - Analyst rating & recommendation
Streamline Health Solutions, Inc. Classifications & Recommendation:
Streamline Health Solutions, Inc. Price Target
| Target Price | $1.53 |
| Price | $5.18 |
| Deviation |
70.46%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Streamline Health Solutions, Inc. 2026 .
The average Streamline Health Solutions, Inc. target price is $1.53.
This is
70.46%
register free of charge
$1.58
69.59%
register free of charge
$1.52
70.75%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Streamline Health Solutions, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Streamline Health Solutions, Inc. stock has an average upside potential 2026 of
70.46%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 17.90 | 21.24 |
| 20.80% | 18.65% | |
| EBITDA Margin | -17.77% | 10.19% |
| 11.56% | 157.36% | |
| Net Margin | -56.76% | -2.28% |
| 31.40% | 95.98% |
3 Analysts have issued a sales forecast Streamline Health Solutions, Inc. 2026 . The average Streamline Health Solutions, Inc. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $17.9m | 20.80% |
|---|---|---|
| 2026 |
$21.2m
18.65%
Unlock
|
|
3 Analysts have issued an Streamline Health Solutions, Inc. EBITDA forecast 2026. The average Streamline Health Solutions, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $-3.2m | 29.96% |
|---|---|---|
| 2026 |
$2.2m
168.05%
Unlock
|
|
EBITDA Margin
| 2025 | -17.77% | 11.56% |
|---|---|---|
| 2026 |
10.19%
157.36%
Unlock
|
|
3 Streamline Health Solutions, Inc. Analysts have issued a net profit forecast 2026. The average Streamline Health Solutions, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $-10.2m | 45.67% |
|---|---|---|
| 2026 |
$-480k
95.28%
Unlock
|
|
Net Margin
| 2025 | -56.76% | 31.40% |
|---|---|---|
| 2026 |
-2.28%
95.98%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.53 | -0.11 |
| 48.99% | 95.65% | |
| P/E | negative | |
| EV/Sales | 1.65 |
3 Analysts have issued a Streamline Health Solutions, Inc. forecast for earnings per share. The average Streamline Health Solutions, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $-2.53 | 48.99% |
|---|---|---|
| 2026 |
$-0.11
95.65%
Unlock
|
|
P/E ratio
| Current | -2.37 | 44.92% |
|---|---|---|
| 2026 |
-46.17
1,851.97%
Unlock
|
|
Based on analysts' sales estimates for 2026, the Streamline Health Solutions, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.91 | 1.60% |
|---|---|---|
| 2026 |
1.65
13.50%
Unlock
|
|
P/S ratio
| Current | 1.23 | 17.66% |
|---|---|---|
| 2026 |
1.06
13.48%
Unlock
|
|
Streamline Health Solutions, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
